Relapsed ALL – some very good news

Blinatumomab shows excellent efficiecy in relapsed ALL. The results of treatment with this drug are far better than transplantation. Now there is a new clinical trial with this drug.

A great hope for many patients with relapsed ALL

 

http://bloodjournal.hematologylibrary.org/content/120/26/5185.full

 

 

 

Advertisements
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s